Revance Therapeutics Inc (RVNC)

[Emannow]

We are going to wake up one morning and RVNC will be bought! The conditions for purchase are moving in the correct direction!

While global M&A activity had a record year in 2021 in the wake of the COVID-19 pandemic, the sheer number of deals being announced has been tepid for the last two years as high interest rates and inflation make the cost of doing business more expensive. High interest rates have increased borrowing costs and made it more difficult for companies to finance acquisitions, meaning management teams are being more selective with how they allocate capital. However, we’re starting to see inflation cool, with May’s Consumer Price Index coming in lower than expected last Wednesday.2 And as far as interest rates are concerned, both markets and the FOMC expect rates to decline over the next year. The current expectation is for a September rate cut of 25 basis points according to the CME Group FedWatch tool, followed by an additional 25 basis point rate cut at the December meeting.3 If both of these continue to trend lower it should open up the probability of more deal-making towards the end of 2024 and into 2025.